CRE
BCID2 Panel Significantly Reduces Time to Appropriate Therapy in Gram-Negative BSIs
Implementation of the BioFire FilmArray BCID2 (bioMérieux) resulted in clinically significant reduced time ...
AUGUST 6, 2025

Even After Reprocessing, Many Scopes Stay Dirty
More than one in 10 duodenoscopes remain contaminated even after they are reprocessed following protocols ...
APRIL 8, 2020

Antimicrobial Resistance in Perspective: Using New Technology To Help Identify Resistant Pathogens
Antimicrobial resistance is part of natural selection and has existed for millennia. In the community, the ...
DECEMBER 4, 2019

Why Won’t MDs Prescribe New Antibiotics?
There are new and pending antibiotics that are broad-spectrum and highly effective, with favorable safety profiles, ...
SEPTEMBER 20, 2019

Increased Incidence of CRE Reports Due to Definition Change
The prevalence of carbapenem-resistant Enterobacteriaceae (CRE) increased by nearly threefold between 2015 and ...
NOVEMBER 27, 2018

FDA Approves Zemdri to Treat Adults With Complicated UTIs
The FDA approved plazomicin (Zemdri, Achaogen) for the treatment of adults with complicated urinary tract ...
JUNE 26, 2018

Investigational Relebactam Plus Imipenem-Cilastatin Effective Against CRE
A new antimicrobial combination appears effective and safe against CRE.
APRIL 24, 2018

CDC Program Tries to Put Out Spark Before Resistance Spreads ‘Like Wildfire’
Ramped-up CDC strategy helps providers stop spread of new resistant organisms, prevents large outbreaks.
APRIL 3, 2018

Phantom Menace Increasingly Prevalent in U.S. Hospitals
Although not yet associated with outbreaks in the United States, carbapenem-resistant Enterobacteriaceae are ...
MARCH 27, 2018

High Prevalence of CRE in D.C. Health Care Facilities
Colonization can be a predictor for future infections and outbreaks, so it is important for health care ...
JUNE 28, 2017

First U.S. Death From Pan-Resistant Superbug Reported
The CDC reported the first death from carbapenem-resistant Enterobacteriaceae (CRE) that was resistant to all ...
JANUARY 17, 2017
